← Evidence map

ArticleOncoTargets and therapy2020

CD26 as a Promising Biomarker for Predicting Prognosis in Patients with Pancreatic Tumors.

Liang Yan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

6 papers cite it

2020
2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 33335402